The global biopharmaceutical landscape is currently witnessing a massive infrastructure shift, characterized by record-breaking capital investments and...
Chemotherapy and Targeted Therapy
The pharmaceutical and biotechnology sectors are undergoing a period of intense transformation, characterized by a recalibration of...
In a move that signals a significant shift in the landscape of early-stage biotechnology, Remix Therapeutics has...
SAN DIEGO — The biotechnology sector is experiencing a profound resurgence. Following a period of cooling sentiment...
For years, the narrative surrounding classic psychedelics—specifically psilocybin—has been one of clinical salvation. Headlines have promised a...
In the high-stakes arena of pharmaceutical development, the “see-saw” effect is a standard law of gravity. When...
In one of the most significant venture capital infusions of the year, ophthalmology-focused startup Ollin Biosciences has...
By Jonathan Gardner | Published June 23, 2026 In a decisive move to bolster domestic biopharmaceutical competitiveness,...
In 2020, the biotechnology sector witnessed a seismic shift when Bristol Myers Squibb (BMS) executed a $13...
By Delilah Alvarado | June 23, 2026 Pfizer’s strategic pivot toward becoming a global powerhouse in oncology...
